⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2780100 | 0.77 | — | — | |
| SCHEMBL8771999 | 0.74 | — | — | |
| SCHEMBL19944959 | 0.72 | CHRM2 (0.33) | — | |
| Bromide SCHEMBL16762436 | 0.72 | — | — | |
| SCHEMBL1416366 | 0.70 | — | — | |
| SCHEMBL514392 | 0.70 | — | — | |
| SCHEMBL1416114 | 0.70 | — | — | |
| SCHEMBL11786076 | 0.67 | — | — | |
| SCHEMBL17194015 | 0.67 | CHRM1 (0.40) | — | |
| SCHEMBL10614 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758341-B1 | FACTOR Xa INHIBITORS | AVENTIS PHARMA INC (US) | 2004-03-24 | — | — | EP | claimed |
| US-20020173646-A1 | Quinazoline derivatives and pharmaceutical compositions containing them | ZENECA LIMITED | 2002-11-21 | — | — | US | claimed |
| US-4902707-A | Bicyclic pyrazolidinones, compositions and use | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | claimed |
| US-4826992-A | MICROBIOCIDE INTERMEDIATES | ELI LILLY AND COMPANY (US) | 1989-05-02 | — | — | US | claimed |
| US-4078146-A | TREATMENT OF CARDIO-VASCULAR DISORDERS | AKTIEBOLAGET HASSLE (SW) | 1978-03-07 | — | — | US | claimed |
| US-11987715-B2 | Radiation curable ink jet composition and ink jet method | SEIKO EPSON CORPORATION (JP) | 2024-05-21 | — | — | US | disclosed |
| US-20240052185-A1 | Radiation Curable Ink Jet Composition And Ink Jet Method | SEIKO EPSON CORP (JP) | 2024-02-15 | — | — | US | disclosed |
| US-20230348742-A1 | Radiation Curable Ink Jet Composition | SEIKO EPSON CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-4269511-A1 | RADIATION CURABLE INK JET COMPOSITION | Seiko Epson Corporation (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20230174809-A1 | Radiation-Curable Ink Jet Composition And Ink Jet Printing Apparatus | SEIKO EPSON CORPORATION (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20210301158-A1 | Radiation Curable Ink Jet Composition And Ink Jet Method | SEIKO EPSON CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| US-20200131381-A1 | RADIATION CURABLE INK COMPOSITION AND RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2020-04-30 | — | — | US | disclosed |
| EP-0217142-A2 | A polyazaheterocyclic compound | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1987-04-08 | — | — | EP | disclosed |
| EP-0203722-A1 | Bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0202794-A1 | 7-Substituted-2,3-(Dihydro) bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-11-26 | — | — | EP | disclosed |
| EP-0202047-A1 | Pyrazolidinium ylides | ELI LILLY AND COMPANY (US) | 1986-11-20 | — | — | EP | disclosed |
| EP-0183848-A1 | POLYAZAHETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-06-11 | — | — | EP | disclosed |
| US-4398913-A | ALKALINE PASTES | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-08-16 | — | — | US | disclosed |
| US-4065587-A | U.V. Curable poly(ether-urethane) polyacrylates and wet-look polymers prepared therefrom | SCM CORPORATION (US) | 1977-12-27 | — | — | US | disclosed |
| US-3941791-A | OPTICAL BRIGHTENER | BASF AKTIENGESELLSCHAFT (DT) | 1976-03-02 | — | — | US | disclosed |